Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001181431-12-005419
Filing Date
2012-02-02
Accepted
2012-02-02 18:35:35
Documents
1
Period of Report
2012-01-24

Document Format Files

Seq Description Document Type Size
1 LAPORTE ANNUAL GRANT rrd332437.html 4/A  
1 LAPORTE ANNUAL GRANT rrd332437.xml 4/A 3873
  Complete submission text file 0001181431-12-005419.txt   5246
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Issuer) CIK: 0001178711 (see all company filings)

EIN.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
LAPORTE KATHLEEN (Reporting) CIK: 0001196201 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-51967 | Film No.: 12567437